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Abstract
Background: Postoperative delirium is a common disorder in older adults that is associated with higher morbidity
and mortality, prolonged cognitive impairment, development of dementia, higher institutionalization rates, and
rising healthcare costs. The probability of delirium after surgery increases with patients’ age, with pre-existing
cognitive impairment, and with comorbidities, and its diagnosis and treatment is dependent on the knowledge of
diagnostic criteria, risk factors, and treatment options of the medical staff. In this study, we will investigate whether
a cross-sectoral and multimodal intervention for preventing delirium can reduce the prevalence of delirium and
postoperative cognitive decline (POCD) in patients older than 70 years undergoing elective surgery. Additionally,
we will analyze whether the intervention is cost-effective.
Methods: The study will be conducted at five medical centers (with two or three surgical departments each) in
the southwest of Germany. The study employs a stepped-wedge design with cluster randomization of the medical
centers. Measurements are performed at six consecutive points: preadmission, preoperative, and postoperative with
daily delirium screening up to day 7 and POCD evaluations at 2, 6, and 12 months after surgery. Recruitment goals
are to enroll 1500 patients older than 70 years undergoing elective operative procedures (cardiac, thoracic, vascular,
proximal big joints and spine, genitourinary, gastrointestinal, and general elective surgery procedures).
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Discussion: Results of the trial should form the basis of future standards for preventing delirium and POCD in surgical
wards. Key aims are the improvement of patient safety and quality of life, as well as the reduction of the long-term risk
of conversion to dementia. Furthermore, from an economic perspective, we expect benefits and decreased costs for
hospitals, patients, and healthcare insurances.
Trial registration: German Clinical Trials Register, DRKS00013311. Registered on 10 November 2017.
Keywords: Cross-sectoral care, Delirium prevention, Postoperative cognitive dysfunction, Dementia, Older patients,
Elective surgery, Quality of life, Cost-effectiveness
Background
Delirium is associated with increased morbidity and mor-
tality, cognitive impairment, dementia, and higher
institutionalization rates [1]. The incidence of postopera-
tive delirium (POD) depends on factors predisposing to
delirium such as age, the presence of brain damage, de-
mentia, deficits in cognitive, sensory, or mobility func-
tions, multiple comorbidities, polypharmacy, and frailty
[2]. Early indicators of cognitive deficits, including hypos-
mia [3], sleep disorders [4, 5], and subjective memory im-
pairment [6, 7], are also relevant risk factors for delirium.
The perioperative phase is a major trigger of postoperative
delirium because of the administration of anesthesia, the
surgical procedures, and other factors related to the oper-
ation itself, such as pain and immunological activation [2].
Postoperative cognitive dysfunction (POCD) often appears
after POD [8, 9] and has been studied in relation to the
preoperative status in order to measure the delirium’s im-
pact, particularly on the risk of developing dementia [10],
and in order to estimate the related health costs. POD and
POCD are associated with higher mortality and postoper-
ative complications (such as infections, falls, decubitus ul-
cers, incontinence) [9], with prolonged hospital stays [11],
with the need for longer/extended intensive care and ther-
apy and higher nursing workload burden [12], and with
increased costs for both hospitals and healthcare insur-
ance providers [2, 13].
Delirium is a healthcare quality indicator in older
adults, and therefore delirium prevention is an essential
parameter for patients’ safety [14, 15]. The incidence of
delirium and its severity and duration can be signifi-
cantly decreased and may be stratified by taking delirium
risk factors into account [16]. Current guidelines for
POD management [17] emphasize the importance of de-
lirium prevention. A multimodal nonpharmacological
approach [14, 18] is considered the best pathway [16,
19]. In a meta-analysis [20], this approach reduced the
delirium risk by 53% (95% CI, 0.38 to 0.58) when com-
paring intervention and control groups.
For elective surgery, it is possible to implement a pread-
mission delirium prevention plan [21], adapting care to the
patient’s age and delirium risk. However, surgical centers
typically do not implement preadmission procedures for
delirium risk assessment, and recommended interventions
for the management of delirium are not standardized.
In this study, we will develop a cross-sectoral and
“best practice” multimodal delirium prevention approach
in five medical centers. The proposed multisectoral model
for delirium prevention integrates and builds upon several
multimodal admission models [16] with preadmission risk
reduction counseling (“prehabilitation”), perioperative
monitoring [22], and training based on international
guides [17, 23] of multidisciplinary patient care providers,
including operation room personnel, service staff, and
families. The study will optimize delirium assessment,
establish a cross-sectoral intervention bundle for
preventing delirium, and evaluate the effectiveness and
cost-efficiency of this all-encompassing approach. To this
end, evidence-based delirium diagnoses, neuropsycho-
logical tests, and multimodal multiprofessional interven-
tions will be implemented. Follow-up POCD evaluations
will be performed 2, 6, and 12months after surgery. Fur-
thermore, relatives will be asked about their care burden,
and a cross-sectoral analysis of the perioperative patient
pathway will be performed.
The project, recruiting a total of 1500 patients, has the
following objectives:
a) The evaluation of the perioperative delirium
prevalence with the I-Confusion Assessment
Method-based scoring system for delirium diagnosis
and delirium severity (I-CAM-S) [9], which is used
for the first time in a large multicenter German
sample.
b) The implementation of a multisector, individualized,
multiprofessional and multimodal delirium and
POCD prevention program.
c) The evaluation of the prevalence of POCD at 2 and
6months after surgery, and the persistence of POCD
after 12months.
d) The evaluation of changes in medication during the pre-
admission and perioperative phases, especially with re-
spect to avoidance of anticholinergic drugs and other
pharmacologic agents associated with delirium.
e) The evaluation of the care burden of the patients’
relatives.
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f ) The economic evaluation of the multimodal
intervention, studying its cost-effectiveness. From
the point of view of the hospital departments, initial
hospital costs will be evaluated. From the point of
view of the health and care insurance company
Allgemeine Ortskrankenkasse (AOK) Baden-
Württemberg (Germany), inpatient and outpatient
costs during the 12 months before and after the




We have designed a cross-sectoral longitudinal study that
aims to include 1500 patients undergoing elective surgery.
The study employs a stepped-wedge design with cluster
randomization of five medical centers. The study will have
seven periods, each lasting 12 weeks (see Fig. 1). The study
will evaluate an all-encompassing “best practice” multi-
modal intervention for preventing delirium and POCD
that includes six consecutive measurement points: pread-
mission, preoperative, and postoperative including daily
delirium screening for 7 days after surgery and 2, 6, and
12months after surgery. We aim to show that: the
cross-sectoral multimodal and multidisciplinary interven-
tion reduces the delirium rate by at least 40% compared
with treatment as usual; the cross-sectoral multimodal
and multidisciplinary intervention reduces the rate of
postoperative cognitive decline by at least 20% compared
with treatment as usual; and the cross-sectoral interven-
tion, including the team training and the modules for non-
pharmacological prevention, is cost-effective and therefore
the improvement in quality of life imposes no additional
costs because the care needs of the patients and caregivers
are lower than with the standard treatment.
The study strategy is registered, constructed, and pre-
sented according to the recommendations of the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) [24, 25] (see Additional file 1: SPIRIT
checklist). The items from the World Health Organization
Trial Registration Data Set are presented in Table 1.
Trial overview
The consortium leader will manage the project, oversee
the financial transfers, monitor the progress according
to the planned schedule, and communicate with the
study sponsor Innovationsfonds des Gemeinsamen Bun-
desausschusses. The consortium leader is also part of
the steering committee, whose main tasks are dealing
promptly with the everyday project issues, monitoring
the recruitment progress and the implementation of the
intervention modules, and managing the study docu-
mentation. The members of the steering committee are
also part of the project committee, which includes two
members from each study site. The project committee
accompanies the study and coordinates the joint publi-
cations as well as the requests for data analysis. If neces-
sary, the project committee, based on interim analyses
performed every 3 months, can decide on early termin-
ation of the project. Moreover, in its meetings every 6
months, the committee may deal with any relevant pro-
ject issues. An international scientific advisory board of
well-established professionals, including a geriatrician,
an anesthetist, a gerontologist, and a delirium expert, en-
sures the scientific quality of the trial. The advisory
board is comprised of four delirium and POCD experts.
An external Regional Ethics and Data Monitoring Board
(REDMB) includes national experts on delirium and
POCD who are independent of the sponsor and trial in-
vestigators, and have no competing interests. They may
be called upon to deal with ethically difficult issues, and
they will also act as a monitoring board for adverse
events (AEs). Furthermore, if the trial was to terminate
early, the REDMB would take part in that decision.
Participants
Inclusion criteria
Eligible patients are aged 70 years or older and sched-
uled for elective surgery (cardiac, thorax, vessels, prox-
imal large joints or spine, genitourinary, abdominal, or
general elective surgery procedures) with a planned dur-
ation of surgery of at least 60 min (cut-to-suture time)
under general, spinal, or regional anesthesia. As delirium
is a high risk in dementia and frailty, we include patients
Fig. 1 Timeline and randomization
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with dementia or frailty who can consent to the trial or
whose substitute decision-makers provide consent.
Exclusion criteria
Patients undergoing emergency surgery procedures,
patients unable to consent due to insufficient mastery of
the German language or with newly discovered severe de-
mentia (red flag: Mini Mental State Examination (MMSE)
< 15, Montreal Cognitive Assessment (MoCA) < 8) with-
out a substitute decision-maker, patients with a poor clin-
ical prognosis (expected survival of less than 15months),
and patients who have a long driving distance to the study
site (> 120 km) are to be excluded from the trial.
The recruitment procedure is described in Fig. 2. Pa-
tients who are not able to consent may also be recruited
if the legal guardian consents to the patient’s study par-
ticipation, given that such patients are especially at risk
of developing delirium and POCD after surgery [10],
and they could eminently benefit from the intervention.
Intervention
The intervention implements a cross-sectoral all-encompassing
multimodal delirium prevention and management ap-
proach, and will be carried out in each study center after
the center is randomized to take part in the intervention
phase of the trial:
1. All personnel training: within 4–6 weeks before the
start of the intervention phase, nurses and
therapeutic, medical, and support staff involved in
the care of study patients will be trained with
respect to dementia and delirium care, delirium
diagnosis, and depression using a standardized
training plan. Staff will be trained to three different
levels of expertise: more than 70% of the staff are to
receive basic training (90-min training time); more
than 20% of nurses are to receive advanced training
(“delirium scout” training—450-min training time);
and more than 10% are to receive expert-level
training (“delirium champion” training—900-min
Table 1 Items from the World Health Organization Trial Registration Data Set
1 Primary registry and trial-identifying number: DRKS-ID, DRKS00013311
2 Date of registration in primary registry: 10 November 2017
3 Secondary identifying numbers: no
4 Sources of monetary or material support: Innovation Fund of the Federal Joint Committee (G-BA): VF16012
5 Primary sponsor: University Hospital Tübingen
6 Secondary sponsor(s): (to be found)
7 Contact for public queries: Prof. Dr med. Gerhard Eschweiler, Geriatric Center of the University Hospital Tübingen; PD. Dr med. Christine Thomas,
Klinikum Stuttgart
8 Contact for scientific queries: Prof. Dr med. Dr phil. Michael Rapp, Social and Preventive Medicine, Potsdam University
9 Public title: PAWEL: Patient safety, cost-effectiveness and quality of life: reduction of delirium risk and post-operative cognitive dysfunction after
elective procedures in the elderly
10 Scientific title: see 9
11 Countries of recruitment: Germany, Baden-Wuerttemberg
12 Health condition(s) or problem(s) studied: delirium, postoperative cognitive dysfunction (POCD)
13 Intervention(s): trans-sectoral multimodal perioperative intervention for elective surgical interventions vs treatment as usual (TAU)
14 Key inclusion criteria: patients older than 70 years undergoing an elective surgery (heart, thorax, vessels, proximal big joints and spinal cord,
genitourinary, gastrointestinal, and general elective surgery procedures) with at least 60-min duration of anesthesia (cut-to-suture time)
Key exclusion criteria: emergency surgery, newly discovered severe dementia (red flag: Mini Mental State Examination (MMSE) < 15, Montreal
Cognitive Assessment (MoCA) < 8) without caregiver holding power of attorney, 120 km of driving distance to the center, inability to consent
due to decreased German language abilities, poor clinical prognosis (survival < 15 months)
15 Study type: stepped wedge cluster randomized design
16 Date of first enrolment: 20 November 2017
17 Target sample size: 1800 for the delirium risk score, 1500 thereof for comparison of intervention
18 Recruitment status: enrolling by invitation
19 Primary outcome(s): delirium prevalence, measured by daily delirium screening (I-Confusion Assessment Method-based scoring system for delirium
severity (I-CAM-S)) over 7 days post surgery, as well as after 2 and 6 months; Nursing Delirium Screening Scale (NuDESC) on days 2 and 6 post surgery
20 Key secondary outcome(s): delirium duration as described in the primary outcome assessment. Prevalence of POCD 2 and 6 months after surgery
as measured by a neuropsychological test battery (Montreal Cognitive Assessment (MoCA), digit span backwards and Trail Making Test A and B
(TMT A and B)) as well as cognitive performance measured with the continuous nonstandardized test values of these scales. A cognitive deficit is
defined as the presence of a test value ≤ 0.5 standard deviations, normalized for age, gender, and education, in one of these test procedures
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training time). Additionally, at least 70% of the
physicians will receive 90 min extra of specific
training about delirium risk, diagnosis, treatment,
and prevention. The courses will be adjusted to the
specific surgical and anesthesiological departments
and special care units in order to ensure comparable
levels of knowledge between different study sites.
2. Environmental orientation support: the hospital
environment will be adapted to the special needs
of the patients. The decline of sensory function in
older adults often leads to additional psychosocial
stress, and is exacerbated by cognitive impairment.
To address these issues, appropriate posters and
signage will be placed on the wards, and in patients’
rooms and restrooms. Tools for temporal and
situational orientation will be made available; for
example, whiteboards with personal information, date,
season, and year, as well as analog clocks that can be
seen from the bed. Moreover, appropriate tools to
prevent falls will be provided, such as anti-sliding
socks. Special boxes for glasses, hearing aids, and
dentures, as well as sleeping masks and ear plugs will
be within reach of the patients at all times.
3. Preadmission phase: the trained staff will implement
some nonpharmacological preventive interventions in
this phase, including informative talks and written
recommendations for patients, and instructive
contacts with the referring doctors regarding the
age-appropriateness of prescribed medications
and interventions.
4. “Best practice” multimodal intervention: participants
at the respective centers will receive perioperative
and postoperative multimodal delirium prevention
and care management between 8 a.m. and 8 p.m.
on 7 days of the week, modified according to best
practice models such as the Hospital Elder Life
Program (HELP) [26], “The old patient in the surgery
room” [22], or the Care of Confused Hospitalised
Older Persons (CHOPs) [27]. Psychogeriatric nurses
and one physician who have received 900 additional
minutes of “delirium champion” training will form
a multiprofessional consultation–liaison-like
intervention team that will contact the patients and
address their special needs daily. They will facilitate
the implementation of the treatments advised in
international delirium prevention guidelines [17, 23]:
adaptation of surgery and anesthesia, medication and
pain treatment appropriate for the patients’ age,
pain monitoring, avoidance of movement restrictions
such as catheters or infusions, and avoidance of
benzodiazepines and anticholinergic drugs. These
specialists will prescribe meaningful individualized
daily activities for preventing delirium, defined in
six modules: reorientation, cognitive activation,
mobilization, meal companionship, clinical
diagnostics and operation room attendance, and
nonpharmacological sleep promotion and anxiety
reduction. A team of nurses’ aides or volunteers
(mostly gap-year social work volunteers) will
carry out these activities, as well as chaperone
Fig. 2 Recruitment procedure. PAWEL Patient safety, cost-effectiveness and quality of life: reduction of delirium risk and post-operative cognitive
dysfunction after elective procedures in the elderly
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patients during the diagnostic procedures, and in the
operating and recovery rooms. They will receive
40 h of theoretical and practical training on the
modules, and will be available daily in two shifts of
12 h per day.
5. Patients and their family members will be advised
individually about delirium risk and prevention, and
will receive information materials (leaflets, posters,
etc.) about delirium and the care service. Moreover,
family members will provide individual information
about the patient, facilitating individualized care
and communication, and will be advised to support
some individualized delirium prevention activities.
Given the patient-centered care research implementa-
tion goal of this study, the outcomes of patients
undergoing the intervention will be compared to the
outcomes of patients receiving treatment as usual (TAU)
provided by the centers before the randomized start of
the intervention.
Patient group involvement and staff involvement has
been implemented in an earlier version of this interven-
tion approach adapting the HELP (Hospital Elderly Life
Program) structure (see [18]). In addition, we will imple-
ment focus groups at the general practitioner level post
hospital stay to further evaluate patients’ perception of
the intervention itself.
Adherence to intervention
The training modules are expected to play a fundamental
role in improving adherence to the intervention protocols.
They will be supplemented by additional talks, case dis-
cussions, and a web-based knowledge base providing
webinars, training videos, and so forth. Moreover, a sup-
port system for the intervention teams will be established
comprising an email service and a telephone hotline, as
well as a data pool on a project server. Modules prescribed
by the intervention team will be monitored, and the time
span of the intervention will be daily documented.
Furthermore, adherence to the manuals and “prescrip-
tion checklists” will be tested by unannounced visits
to every site.
Adverse events
Adverse events and serious adverse events (SAEs) will
be recorded and documented. Falls, strokes, infections,
and other severe perioperative complications (death, re-
operation, pneumonia, sepsis) are to be expected in this
patient group independently of the intervention, while
SAEs related to the intervention are expected to be very
rare. An example of a study-related SAE could be, for in-
stance, a patient’s fall during early mobilization by the
delirium companion during the active intervention
phase. The feasibility of the project and the occurrence
of SAEs will be assessed every 3 months by the REDMB,
who will also carry out audits every year. In the case of
substantial differences between the SAEs in the different
groups, this will be discussed by the REDBM.
Withdrawal
The criteria for discontinuing the intervention for a par-
ticipant will be death; or study withdrawal requested by
the patient, guardian, or authorized relative; or (re)oper-
ation of more than 1 h (cut-to-suture time) during the
first perioperative week, given that in this case a delir-
ium or POCD cannot be precisely assigned to the first
operation; or malignancy surgery with prognosis under
15months, neoadjuvant chemotherapy, brain radiother-
apy, or primary metastasis surgery for pancreas or bron-
chial cancer.
Outcome assessment
The assessment of all the outcomes will always be per-
formed by trained assessors, who will be blinded for the
intervention. Specifically, delirium raters will be told that
the data will be used for validating a delirium risk score.
Staff will be instructed not to reveal the nature of the
intervention to these assessors.
The primary outcome will be delirium prevalence. It will
be measured by daily delirium screening (I-Confusion As-
sessment Method-based scoring system for delirium se-
verity (I-CAM)/CAM-S)) [28, 29] over 7 days after surgery
and after 2 and 6months, the Nursing Delirium Screening
Scale (NuDESC) [30] (days 2 and 6 after surgery), a chart
review at discharge applying the DSM-V delirium criteria
as a reference standard [31], and the clinical evaluation.
The CAM [32], with its four-step diagnostic algorithm,
is a widely used screening test for assessing delirium.
Originally developed from the DSM-III-R, it is now pre-
dominantly used for delirium screening and research ac-
cording to the DSM-IV and DSM-V criteria. It has been
operationalized and translated into German [33], and
then revealed a high sensitivity of 0.77 in a cohort of
geriatric patients with a high prevalence dementia, and a
specificity of 0.96–1.00 with excellent inter-rater reliabil-
ity (Cohen’s κ = 0.95 (CI 0.74–1.0) for the algorithm,
single item’s κ values varied between 0.5 and 1).
The I-CAM (I for ICD-10) [28] extends the German
version of the original CAM adding abnormal psycho-
motor activity, to allow taking also the ICD-10 delirium
diagnosis as a reference standard and assessing the
motor delirium subtypes as well. The CAM-S [29] is a
CAM-based scoring system for assessing delirium se-
verity and was operationalized for use with the German
version of the I-CAM. As the CAM might be con-
founded by the fluctuating nature of delirium, we use a
chart-based review [31] filled out by trained medical
staff at discharge to evaluate for fluctuations in
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sleep–wake rhythm or psychomotor activity indicating
delirium.
The NuDESC is a five-item scale based on nurses’ ob-
servations assessing disorientation, inappropriate behavior
and communication, hallucinations, and psychomotor re-
tardation over a 24-h period. For the German version of
the NuDESC, in a sample of patients after elective surgery,
a sensitivity of 0.98, a specificity of 0.92, and an inter-rater
reliability of 0.83 were observed [34].
The secondary outcomes will be: delirium duration as
described in the primary outcome assessment; preva-
lence of POCD 2 and 6months after surgery; and per-
sistence of POCD after 12 months. The prevalence of
POCD will be measured by the following neuropsycho-
logical test battery: the Montreal Cognitive Assessment
(MoCA) [35], the digit span backwards [36], the Trail
Making Test A and B (TMT A and B) [37], and cognitive
performance measured with the continuous nonstan-
dardized test values of these scales. A cognitive deficit is
defined as the presence of a test value of ≤ 0.5 standard
deviations, normalized for age, gender, and education, in
one of these test procedures.
The MoCA is a brief cognitive screening test for asses-
sing cognitive impairment among older people. The test
assesses multiple cognitive domains including visuo-
spatial ability, executive functions, memory, attention,
language, abstraction, and orientation. The MoCA has
high sensitivity (0.90) and specificity (0.87) to detect in-
dividuals with mild cognitive impairment and distinguish
them from cognitively intact older people [35] and is
available in three parallel versions.
The digit span backwards is commonly used to as-
sess working memory capacity. Participants are re-
quired to recall a sequence of spoken digits in reverse
order. For people older than 70 years, the digit span
backwards had a test–retest reliability > 0.60 and an
internal consistency of 0.882 [38].
The TMT is a widely used instrument in neuro-
psychological assessment that measures the speed of
scanning and visuomotor tracking, divided attention,
and cognitive flexibility [36]. The test consists of two
parts, A and B. TMT A requires an individual to draw
lines sequentially connecting consecutive numbers
from 1 to 25. TMT B involves drawing a similar line,
connecting an ascending sequence of numbers and let-
ters in an alternating manner. In a sample of healthy
older adults, Part A had a test–retest reliability of 0.78
and Part B of 0.73, and Part A an inter-rater reliability
of 0.99 and Part B of 0.93 [39]. In a sample of elderly
volunteers, Part B had a sensitivity of 0.63 for cognitive
dysfunction, 0.72 for dementia, and 0.77 for AD, and a
specificity of 0.89 [40].
For baseline assessment, the following variables will be
evaluated. Basic sociodemographic patient information
to be collected includes age, gender, weight, height,
dominant hand, marital status, immigrant background,
educational level, occupation, living arrangements, nico-
tine consumption, alcohol consumption, falls, and statu-
tory level of care dependency. The self-reported
subjective memory impairment (SMI) will be assessed,
for which subjects will be asked “Do you feel that your
memory is getting worse?” (no; yes; I don’t know). If the
patient answers yes, the patient will then be asked
whether he or she is worried about this (no; yes, that
worries me; yes, that worries me very much; I don’t
know, no answer) [41]. The personal medical history, in-
cluding comorbidities, is to be quantified by the ex-
panded version of the Charlson’s comorbidity Index
(CCI) [42]. The patient’s preoperative physical status will
be assessed by the American Society of Anesthesiologists
Physical Status classification (ASA) [43]. The risk of
stroke will be estimated with the CHA2DS2-VASc score
(Congestive heart failure/left ventricular dysfunction,
Hypertension, Age > 75, Diabetes, Stroke/transient
ischemic attack/thromboembolism, Vascular disease,
Age 65–74, Sex category) [44]. Laboratory results
(hemoglobin, sodium, creatinine, total amount of pro-
tein, C-reactive protein), the history of delirium in the
past, and a neurological examination will be recorded.
The grip strength as a frailty marker will be measured
with the Jamar® Hydraulic Hand Dynamometer. Hearing
and visual integrity will be tested by the whisper and vis-
ual acuity tests [45]. Functional mobility and risk of falls
will be investigated by the Timed Up and Go Test
(TUG) [46]. Anxiety and depression will be assessed by
the Patient Health Questionnaire (PHQ-4) [47]. The
health-related quality of life will be measured by the
EuroQol five dimensions questionnaire (EQ-5D-5 L)
[48, 49] (this version includes five levels of severity in
each of the existing five EQ-5D dimensions) and by
the 12-Item Short Form Survey (SF-12) [50, 51]. Nu-
tritional status will be assessed by the Mini Nutri-
tional Assessment Short Form (MNA-SF) [52, 53].
Functional status will be evaluated with the Hamburg
Classification Manual [54] version of the Barthel
Index [55]. Frailty will be analyzed with the Clinical
Frailty Scale of the Canadian Study of Health and
Aging (CSHA Clinical Frailty Scale) [56]. Pain will be
measured by the Numerical Rating Scale of Pain
(NRS Pain) [57]. Sleeping behavior will be investigated
by the Pittsburgh Sleep Quality Index—Basic
(PSQI-Basic), a four-item version of the PSQI [58].
Sleep apnea will be screened for by the STOP-BANG
questionnaire (Stop-BANG) [59]. Olfactory function
will be scrutinized by the Sniffin’ Sticks 12 version
[60]. Cognitive decline will be assessed by the very
short version (seven items) of the Informant Ques-
tionnaire on Cognitive Decline in the Elderly
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(IQCODE) [61]. The subjective burden of the family
caregivers will be measured by the German Zarit
Burden interview (G-ZBI) [62, 63]. Classification as a
geriatric patient, will be assessed with the Geriatric-
Check using the geriatric concept of Baden-Württem-
berg (GC) [45]. Finally, the patient’s medications will
be recorded, including the type, dose, and frequency
of administration.
For planned analysis, the following variables are
currently anticipated: anxiety and depression will be
evaluated with the PHQ-4 questionnaire, the
health-related quality of life with the EQ-5D-5 L ques-
tionnaire and the SF-12 survey, the nutrition status
with the MNA-SF, the functional status with the
Barthel Index, and the frailty with the CSHA Clinical
Frailty Scale and hand grip. The duration and extent
of use of physical restraints and patient care atten-
dants will also be assessed. Moreover, the relevant as-
pects of behavior in daily life will be assessed by the
Nurses’ Observation Scale for Geriatric Patients
(NOSGER II) [64, 65], the presence of cognitive de-
cline will be assessed by IQCODE evidenced by rela-
tives, and the subjective burden of family caregivers
by G-ZBI. The timelines are summarized in Fig. 3.
For planned validity assessment of postoperative de-
lirium, the validity of the I-CAM-S and NuDESC vs
the Richmond Agitation-Sedation Scale (RASS) [66]
and vs chart review will be evaluated. The RASS is a
simple observational scale that quantifies the level of
consciousness, assessing both sedation and agitation.
For analysis of delirium severity, the duration and ex-
tent of restraints and one-to-one supervision require-
ments will be used, in addition to the CAM-S score.
For process analysis, acceptance and feasibility will be
evaluated by qualitative assessment using focus groups
formed by members of the geriatric centers.
For planned health-economic analyses, the initial hos-
pital costs and the costs per delirium of two centers
(Tübingen and Stuttgart) will be assessed. Moreover, for
the patients whose health insurance is AOK
Baden-Württemberg (Germany), health and care insur-
ance expenditures and utilization will be assessed, in
particular regarding hospital care, outpatient care, medi-
cation, rehabilitation, and nursing care. For a precise
evaluation of the costs, the expense for training and staff
carrying out the intervention will be included in the
analyses.
Timelines
The study started in November 2017, and the recruit-
ment phase will last until April 2019.
There will be three follow-up examinations after 2, 6,
and 12 months, with the last planned for April 2020. We
plan to complete the evaluations and cost analyses by
December 2020.
From the patient’s perspective, the study will start with
a preadmission screening (T0, at most 3 weeks before
admission) (see Fig. 3). Admission (T1) will be followed
by surgery and then daily delirium screening for 7 days
(T2–T8) during hospitalization. A final discharge assess-
ment (T9) will take place 1–8 days after surgery. If, at
this point, the patient is considered to suffer from delir-
ium, then delirium screening and monitoring will con-
tinue for another 2 weeks, so long as the patient remains
hospitalized in the center. The discharge examination
(T9) will take place, at the latest, 3 weeks after the elect-
ive surgery, with the participation of a physician who
will note any postoperative complications. Follow-up as-
sessments will be performed after 2 months (T10), 6
months (T11), and 12 months (T12). Moreover, the pa-
tient’s relatives will be asked at T12 about their care bur-
den using the G-ZBI, and the cognitive state of the
patient will be assessed using the IQCODE instrument.
If a patient is unable or unwilling to go to the regional
center for any follow-up assessment, the local PAWEL
team will offer the assessment either at some hospital
closer to the patient or at the patient’s general physi-
cian’s practice. If the patient is not able to go to any of
these places, a team member will assess the patient at
the patient’s home. Finally, if the patient refuses this op-
tion, he or she will be asked for a telephone interview.
Sample size
The power analysis for the primary outcome of delirium
prevalence assumes a reduction in the outcome from
25% to 15% [20] as a result of the intervention. A con-
ventional analysis to detect differences in proportions
(delirium rate) between the intervention and control
groups, using Fisher’s exact test, results in a total of
514 patients with a 1:1 randomization, given a power
of 1 – β = 0.80 and an α error of 5%. Using the adjust-
ment form proposed by Woertman et al. [67] with five
crosspoints in a stepped-wedge design, with a max-
imum of 50 patients per cluster per period and an
intracluster correlation of 0.01, leads to a correction
factor for the stepped-wedge design of KF = 2.63, and
therefore a number of 514 × 2.63 = 1351 patients. As-
suming a dropout rate of 15%, this leads to a total re-
quirement for about 750 patients per arm. The
minimum number of clusters is given by the ratio of
the total number of patients to the product between
the number of crossing points and the patients per
cluster per period, and is 15.
For the secondary outcomes, a reduction of the persist-
ent cognitive deficit from 20% to 10% results in 428 pa-
tients using the conventional analysis with Fisher’s exact
test and a 1:1 randomization, a power of 1 – β = 0.80, and
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an α error of 5%, which after the design correction leads
to a requirement of 1079 patients.
Thus, the planned sample size is of at most 1500
patients (see Fig. 1 with the numbers per period).
Furthermore, relatives of the patients will be asked
about the burden of caring and the cognitive status
of the patients.
Recruitment
The study takes place in Germany in the state of
Baden-Württemberg. The study will be performed in uni-
versity hospitals in Tübingen, Freiburg, and Ulm, and in
tertiary care hospitals (one in Stuttgart and two in
Karlsruhe). In total, five medical centers (one per city)
with 12 surgical departments (three in Stuttgart and
Tübingen, and two at the other centers) are included. To
balance the surgical subspecialties per center, recruitment
is restricted to a maximum of 2/3 from one of the follow-
ing surgical subspecialties: orthopedics, vessels and car-
diac, or abdominal. We intend to maintain this ratio for
every center and for every 12-week interval of the study.
Patient recruitment will be carried out by a medical
specialist. Study staff, including doctors and scientists,
will provide the necessary information and obtain the
written informed consent from the patients, and when-
ever possible also from one relative (to assess the care-
giver burden and the cognitive status of the patient).
The medical directors and the managers of anesthesia
and nursing at the hospitals included in the study have
provided a letter of intent expressing their interest in
introducing and evaluating preventive procedures, and
their willingness to recruit the necessary number of pa-
tients. Hence, the recruiting objective is realistic. How-
ever, if a department fails to meet its recruitment target
(17 patients for the departments in Stuttgart and Tübin-
gen, 25 patients for the others) during one period, con-
crete and binding measures will be taken to reach the
planned number of patients. In this case, the center will
commit either to increase the recruitment in its depart-
ments or to include another surgical department. If sev-
eral departments do not reach their target, then the five
recruitment blocks, each lasting 3 months, will be ex-
tended to 4 months, adding 33% more time to recruit. In
this case, for the patients recruited during the last period
of the project, the POCD assessments would be com-
pleted after 6 months instead of after 12 months.
Randomization
Randomization will take place at the cluster level (k = 5
clusters) using a computer-generated sequence. Five
months before starting the intervention in a given center,
that center and the training team in Stuttgart will be in-
formed about the allocation to prepare for the training and
to form the intervention teams. Otherwise, randomization
allocation will only be known to the consortium leader
and the scientific staff at the University of Potsdam, who
will implement the random sequence generation.
Data management
The collection of the clinical data during all stages of
the study (preadmission, admission and postopera-
tively) will be performed exclusively by authorized staff
of the study sites, using electronic Case Report Forms
(eCRFs) via the web-based electronic data capture
(EDC) system secuTrial® from interActive Systems
GmbH. The access to the secuTrial® platform is pro-
tected by an authentication process, and the transmis-
sion of data between the study centers and the
secuTrial® server is protected by a secure connection
using Secure Sockets Layer (SSL) encryption. All col-
lected data will be checked for reliability and validity
every 3 months. Data access will be granted initially to
project and data management and consortium leaders.
All the data from scales and neuropsychological tests,
as well as the clinical data and the data for the
health-economic analysis, will be stored in a pseudony-
mized fashion. After the end of the study, all paper and
electronic documents will be stored for at least 10
years more.
Statistical analysis
For the primary outcome, logistic regression analyses
with cluster adjustment are planned.
For the secondary outcomes, the changes in the medi-
cation and the care burden of the patients’ relatives, we
plan analyses using mixed linear and logistic regression
(See figure on previous page.)
Fig. 3 Standard Protocol Items: Recommendations for Interventional Trials figure of enrollment, intervention, and assessments. CSHA Clinical
Frailty Scale of the Canadian Study of Health and Aging, EQ-5D-5L EuroQol five dimensions questionnaire, G-ZBI German Zarit Burden interview,
I-CAM-S I-Confusion Assessment Method-based scoring system for delirium severity, IQCODE Informant Questionnaire on Cognitive Decline in the
Elderly, MNA-SF Mini Nutritional Assessment Short Form, MoCA Montreal-Cognitive Assessment, NOSGER II Nurses’ Observation Scale for Geriatric
Patients, NRS Pain Numerical Rating Scale of Pain, NuDESC Nursing Delirium Screening Scale, PHQ-4 Patient Health Questionnaire, PSQI (Basic)
Pittsburgh Sleep Quality Index (Basic), RASS Richmond Agitation–Sedation Scale, SF-12 12-Item Short Form Survey, SMI subjective memory impairment,
TMT Trail Making Test, V1/V2/V3 parallel versions of the MoCA, STOP BANG Sleep Apnea Questionnaire (snoring, tiredness, observed apnea, blood
presure, body mass index, age, neck circunference, gender)
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models, with fixed and random factors for estimating
heterogeneity over clusters [68].
Subgroup analyses for specific patient groups (e.g., pa-
tients with cardiac surgery regarding cognitive status or
patients with brief hospital stays/brief surgeries) are
planned.
For planned validity assessments of postoperative de-
lirium, the validity of the I-CAM-S and NuDESC vs the
RASS will be evaluated as screening tools for postopera-
tive delirium. Diagnostic test performance of the tools
will be evaluated by receiver operating characteristics
(ROC) analysis.
Missing data (due to nonadherence of a department or
a particular patient) will be documented. We will apply
mixed-effect models, which handle the missing data
without using any imputation method. Mixed-effect
models assume that the missing data are missing at ran-
dom (MAR); that is, when the probability that an out-
come is missing is related to some other fully observable
variable in the model, but not to the variable with the
missing value itself [69].
Regarding the health-economic evaluation, a micro-costing
analysis will be carried out using data from the clinical ad-
ministration of two hospitals (Tübingen and Stuttgart).
Moreover, for the patients insured by a specific health
insurance (AOK Baden-Württemberg) who consent, the
health and care insurance costs of the 12months before
and after surgery will be calculated using a
difference-in-difference approach [70]. In this case, the
target parameter is the cost per avoided POCD. The
cost-effectiveness of the intervention will be calculated
comparing the costs of the intervention group and the
control group. In addition, quality-adjusted life years
(QALYs) will then be calculated using data from the
EQ-5D-5 L form about health-related quality of life, and
applied for calculating the incremental cost-effectiveness.
When possible, subgroup analyses will be carried out, for
example, by age or gender, to determine whether
cost-effectiveness is different in the corresponding groups.
Sensitivity analyses will also be performed. The evaluation
will be carried out following the recommendations of the
“Good practice secondary data analysis” (GPS).
Dissemination policy
Publications about the results of the trial will be submitted
to international journals after being approved by the pro-
ject committee. Use of professional writers will not take
place, and authorship eligibility criteria are specified in the
trial contract and comply with International Committee of
Medical Journal Editors (ICMJE) statements [71].
An analysis of the perioperative patient pathway will
be developed as an outcome of the project. The goal of
this analysis is to adapt the intervention to everyday care
routine and to facilitate its subsequent implementation.
To this end, doctors and other members of the geriatric
centers will meet in 10 focus groups of 10 participants
each. They will discuss exploratory questions about the
needs and sensitivity to delirium and POCD, the know-
ledge about delirium, dementia, and depression, and other
aspects of the study. To ensure the implementation of the
results, they will be disseminated through workshops: at a
training course; at the annual update on dementia (in
cooperation with the medical association of Baden-Würt-
temberg); and at the day of general medicine of the Insti-
tute of General Medicine and Interprofessional Care in
Tübingen. A main result of the project will be a care path-
way including information tools (e.g., flyers) and training
modules for doctors and doctors’ assistants.
Ethics
This is an intervention study in which existing guidelines
and recommendations will be implemented, including the
S3 guideline of the German Society for Anesthesiology
and Intensive Care Medicine (Deutsche Gesellschaft für
Anästhesie und Intensivmedizin (DGAI)), the S3 guideline
of the Working Group in Geriatric Traumatology
(Arbeitsgemeinschaft Alterstraumatologie (AG Alterstrau-
matologie)) of the German Association of Trauma Surgery
(Deutsche Gesellschaft für Unfallchirurgie (DGU)), the
guidelines of the National Institute for Clinical Excellence
(NICE), the guidelines of the American Geriatrics Society
(AGS), and the guidelines of the Difficult Airway Society
(DAS). Ethics approval according to the occupational reg-
ulations (Berufsordnung (BO)) has been obtained for all
centers. All relevant changes will be communicated to the
scientific advisory board, the Regional Ethics and Data
Monitoring Board (REDMB), the relevant institutional re-
view boards (IRBs), and the clinical trial registry. Given
that there are no extra risks, the usual health insurance or
civil liability will cover the risks of the trial, and there will
be no additional medical liability insurance for the study.
For the additional outpatient assessments, patients and
their relatives will be covered by travel insurance.
In the preadmission assessments, it is to be expected
that approximately 40% of the examined patients will have
slight or severe cognitive impairment [72]. However, this
does not necessarily restrict their capacity to consent or
their legal capacity. Following Kim and Caine [73], we
consider that this only occurs when transitioning to a
more severe dementia (MMSE < 19). For those patients,
the possible damage would be the self-stigmatization as a
dementia-endangered person, but the benefit of the inter-
vention would prevail because of its stipulated reduction
of delirium and POCD.
On the other hand, if a previously unrecognized se-
vere cognitive disorder was found, the patient probably
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could not consent, requiring consent from a substitute
decision-maker.
Discussion
This study has several strong features. The study will de-
termine the perioperative delirium prevalence, measured
with I-CAM-S, for the first time in a large multicenter
German sample. Despite its high prevalence and conse-
quences, delirium is often underdiagnosed in hospital-
ized older adults. In particular, this is the case for
hypoactive delirium because patients with this syndrome
are often not disruptive [8]. To tackle this issue, we will
use the five-item I-CAM, a useful diagnostic and screen-
ing tool for ICD-10 delirium that includes abnormal psy-
chomotor activity and is sensitive for the detection of
hypoactive delirium [28].
In addition, we will use a complementary chart review
[31] to ascertain the detection of delirium beyond the
established sensitivity and specificity of the I-CAM.
While we cannot exclude disruptions of blinding of out-
come assessors in this complex trial, we nevertheless
attempted to ensure blinding of the assessors as much as
was feasible in this trial.
Another advantage of the study is the development of a
multisector, individualized, multiprofessional and multi-
modal delirium and POCD prevention program. There is
now strong evidence indicating that such multicomponent
interventions can prevent delirium in hospitalized pa-
tients, and indicating the importance of adequate training
of the involved staff [16].
Another strength of the study is the design as a
stepped-wedge cluster randomized controlled trial,
which allows modeling of effects within and between
sites of the delirium prevention and management pro-
gram. Such evidence is of higher quality than results ob-
tained from nonrandomized studies [74]. In addition, by
using a stepped-wedge design, the intervention will be
made available to all clusters by the end of the trial [75],
avoiding the controversial situation in which control
groups have no intervention.
The study will also investigate whether the intervention
is cost-effective, so that the improvement of quality of life
does not involve higher costs, and the care needs are
lower than without the intervention. Given that delirium
is highly multifactorial and is linked to many other com-
mon geriatric syndromes, it is expected that improving its
diagnosis and treatment will be a very practical and effect-
ive strategy to improve outcomes, decrease costs, and
raise the quality of the healthcare system wide [14].
Finally, the results of the study are intended to be a
milestone for new German guidelines for the prevention
and management of delirium in surgery, and for dealing
with the frequent and insufficiently diagnosed POCD. In
this way, the results of an elective operation will be bet-
ter, the patient safety and quality of life will be improved,
and the long-term risk of dementia will be minimized.
Furthermore, from an economic perspective, diagnosing
cognitive deficits early and minimizing POD and POCD
should be beneficial for patients, caregivers, hospitals,
and healthcare insurances.
Trial status
Recruitment commenced in November 2017.
Additional file
Additional file 1: SPIRIT checklist: recommended items to address in a
clinical trial protocol and related documents. (DOCX 56 kb)
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